{{Rsnum
|rsid=129974
|Gene=CREBBP
|Chromosome=16
|position=3745291
|Orientation=plus
|GMAF=0.05831
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
|Gene_s=CREBBP
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 100.0 | 0.0 | 0.0
| HCB | 55.5 | 40.1 | 4.4
| JPT | 80.5 | 18.6 | 0.9
| YRI | 93.2 | 6.8 | 0.0
| ASW | 93.0 | 7.0 | 0.0
| CHB | 55.5 | 40.1 | 4.4
| CHD | 63.3 | 32.1 | 4.6
| GIH | 68.3 | 27.7 | 4.0
| LWK | 88.2 | 11.8 | 0.0
| MEX | 91.4 | 8.6 | 0.0
| MKK | 96.2 | 3.8 | 0.0
| TSI | 99.0 | 1.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=20689175
|Title=Spectrum of CREBBP mutations in Indian patients with Rubinstein-Taybi syndrome
}}

{{PMID Auto
|PMID=22198373
|Title=Possible influence of CREB1, CREBBP and CREM variants on diagnosis and treatment outcome in patients with schizophrenia.
}}

{{on chip | Affy GenomeWide 6}}
{{on chip | HumanOmni1Quad}}